series-b
Stage
1
Investors
About
intoDNA develops the STRIDE® platform that uses AI-driven assays to detect and analyze DNA damage and repair at the single-cell level, supporting pharmaceutical research and precision medicine.
Explore intoDNA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.